ID28645A - KOMPOSISI-KOMPOSISI ORAL 8-KLORO-6, 11-DIHIDRO-11-(4-PIPERIDILIDENA)- 5H-BENZO(5,6) SIKLOHEPTA (1,2-b) PIRIDINA - Google Patents

KOMPOSISI-KOMPOSISI ORAL 8-KLORO-6, 11-DIHIDRO-11-(4-PIPERIDILIDENA)- 5H-BENZO(5,6) SIKLOHEPTA (1,2-b) PIRIDINA

Info

Publication number
ID28645A
ID28645A IDW20010070A ID20010070A ID28645A ID 28645 A ID28645 A ID 28645A ID W20010070 A IDW20010070 A ID W20010070A ID 20010070 A ID20010070 A ID 20010070A ID 28645 A ID28645 A ID 28645A
Authority
ID
Indonesia
Prior art keywords
piperidylidena
cyclohepta
benzo
dihydro
pyridine
Prior art date
Application number
IDW20010070A
Other languages
English (en)
Indonesian (id)
Inventor
Jim H Kou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID28645(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ID28645A publication Critical patent/ID28645A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20010070A 1998-07-10 1999-07-08 KOMPOSISI-KOMPOSISI ORAL 8-KLORO-6, 11-DIHIDRO-11-(4-PIPERIDILIDENA)- 5H-BENZO(5,6) SIKLOHEPTA (1,2-b) PIRIDINA ID28645A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10

Publications (1)

Publication Number Publication Date
ID28645A true ID28645A (id) 2001-06-21

Family

ID=22348307

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010070A ID28645A (id) 1998-07-10 1999-07-08 KOMPOSISI-KOMPOSISI ORAL 8-KLORO-6, 11-DIHIDRO-11-(4-PIPERIDILIDENA)- 5H-BENZO(5,6) SIKLOHEPTA (1,2-b) PIRIDINA

Country Status (27)

Country Link
EP (3) EP1073438B1 (cs)
JP (4) JP3224379B1 (cs)
KR (1) KR100420641B1 (cs)
CN (1) CN1145485C (cs)
AR (4) AR016044A1 (cs)
AT (2) ATE262904T1 (cs)
AU (1) AU741201B2 (cs)
BR (1) BR9910449A (cs)
CA (2) CA2377178A1 (cs)
CY (1) CY1109279T1 (cs)
CZ (1) CZ300843B6 (cs)
DE (2) DE69916042T2 (cs)
DK (2) DK1380297T3 (cs)
ES (2) ES2214871T3 (cs)
HU (1) HU228448B1 (cs)
ID (1) ID28645A (cs)
IL (1) IL139407A0 (cs)
MY (1) MY116038A (cs)
NO (1) NO331454B1 (cs)
NZ (2) NZ507885A (cs)
PE (1) PE20000761A1 (cs)
PL (1) PL199390B1 (cs)
PT (2) PT1380297E (cs)
SK (1) SK288240B6 (cs)
TW (1) TW575424B (cs)
WO (1) WO2000002560A1 (cs)
ZA (1) ZA200006224B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
AU2005263958B2 (en) * 2004-07-16 2011-04-14 Cipla Limited Anti-histaminic composition
EP2181994B1 (en) 2006-03-31 2014-05-28 Research Foundation Itsuu Laboratory Antimicrobial compounds
US8377995B2 (en) 2007-11-21 2013-02-19 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablet
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
EP2269586B1 (en) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising desloratadine
PT2568970T (pt) 2010-05-10 2019-02-11 Lesvi Laboratorios Sl Formulações farmacêuticas estáveis contendo um anti-histamínico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501205A (ja) 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション ８↓−クロル↓−６，１１↓−ジヒドロ↓−１１↓−（４↓−ピペリジリデン）↓−５Ｈ↓−ベンゾ〔５，６〕シクロヘプタ〔１，２−ｂ〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine

Also Published As

Publication number Publication date
AR021158A2 (es) 2002-06-12
HU228448B1 (en) 2013-03-28
ATE432075T1 (de) 2009-06-15
SK17112000A3 (sk) 2001-12-03
EP1073438B1 (en) 2004-03-31
KR100420641B1 (ko) 2004-03-02
AR016044A1 (es) 2001-06-20
EP1380297B1 (en) 2009-05-27
ES2214871T3 (es) 2004-09-16
IL139407A (en) 2001-10-31
CA2325014C (en) 2002-05-28
JP2005298524A (ja) 2005-10-27
CA2377178A1 (en) 2000-01-20
PL199390B1 (pl) 2008-09-30
DE69940932D1 (de) 2009-07-09
BR9910449A (pt) 2001-01-02
JP4160739B2 (ja) 2008-10-08
JP2002520285A (ja) 2002-07-09
HUP0101900A2 (hu) 2001-11-28
ZA200006224B (en) 2001-11-01
SK288240B6 (sk) 2015-02-03
DE69916042T2 (de) 2004-11-11
AR021159A1 (es) 2002-06-12
PL344045A1 (en) 2001-09-24
TW575424B (en) 2004-02-11
WO2000002560A1 (en) 2000-01-20
EP2055303A3 (en) 2009-12-16
AU4953199A (en) 2000-02-01
IL139407A0 (en) 2001-11-25
NZ512916A (en) 2003-03-28
DE69916042D1 (de) 2004-05-06
DK1073438T3 (da) 2004-05-10
ES2326214T3 (es) 2009-10-05
DK1380297T3 (da) 2009-08-17
CY1109279T1 (el) 2012-05-23
EP1073438A1 (en) 2001-02-07
JP3224379B1 (ja) 2001-10-29
CZ20004056A3 (cs) 2001-03-14
CZ300843B6 (cs) 2009-08-26
PT1380297E (pt) 2009-07-06
AR021157A2 (es) 2002-06-12
AU741201B2 (en) 2001-11-22
CN1145485C (zh) 2004-04-14
HK1030361A1 (en) 2001-05-04
KR20010043402A (ko) 2001-05-25
NO331454B1 (no) 2012-01-09
JP4621082B2 (ja) 2011-01-26
NO20005485D0 (no) 2000-10-31
MY116038A (en) 2003-10-31
EP1380297A1 (en) 2004-01-14
JP2010265329A (ja) 2010-11-25
HUP0101900A3 (en) 2003-01-28
JP2002068983A (ja) 2002-03-08
ATE262904T1 (de) 2004-04-15
PE20000761A1 (es) 2000-08-31
NO20005485L (no) 2001-03-09
EP2055303A2 (en) 2009-05-06
PT1073438E (pt) 2004-07-30
CA2325014A1 (en) 2000-01-20
NZ507885A (en) 2001-08-31
CN1303284A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
LU90738I2 (fr) Desloratadine
SI1129088T1 (sl) Kristalinična oblika (R)-2(((3-metil-4-(2,2,2-trifluoroetoksi)-2-piridinil)metil)sulfinil)- 1H-benzimidazola
NZ222253A (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo c5,6,)cyclohepta c1,2-b)pyridine derivatives and pharmaceutical compositions
DE69814076D1 (de) 8-chlor-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2.b]pyridine polymorphe formen
HUP0101900A3 (en) 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions
ATE274899T1 (de) Im mund zerfallende zusammensetzung mit mirtazapin
AU2003230758A1 (en) 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
DK1068194T3 (da) PDE IV-hæmmende pyridinderivater
ATE258935T1 (de) Furo(3,2-b)pyridine als 5-ht1f agonisten
DE60001054D1 (de) Trizyclische pyridin n-oxide vasopressin agonisten
IL133449A0 (en) Benzo (5, 6) cyclohepta (1, 2-b) pyridine derivatives as farnesyl protein transferase inhibitors
AU9683798A (en) Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo{5,6}cyclohepta {1,2-b}pyridin -11-ylidene)-1- piperidene carboxylate polymorph
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions
KR100463031B1 (ko) 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
ZA877919B (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridines and compositions and methods of use
ES2087026A1 (es) Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina.